Vera Therapeutics, Inc. (VERA) Financials
VERA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 175.6 million | 51.9 million |
2023-06-30 | 195.2 million | 54.7 million |
2023-03-31 | 209.6 million | 51.9 million |
2022-12-31 | 131.4 million | 54.5 million |
VERA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -23.0 million | 2.9 million |
2023-06-30 | -17.8 million | 2.7 million |
2023-03-31 | -26.3 million | 2.7 million |
2022-12-31 | -21.2 million | 2.7 million |
VERA Net Income
No data available :(
VERA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 159.9 million | - | 4.5 million |
2023-06-30 | 181.0 million | - | 5.1 million |
2023-03-31 | 197.2 million | 24.9 million | 5.8 million |
2022-12-31 | 114.7 million | 24.8 million | 6.5 million |
VERA Shares Outstanding
VERA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 16.1 million | 5.7 million | - |
2023-06-30 | - | 16.2 million | 5.7 million | - |
2023-03-31 | - | 25.1 million | 6.2 million | - |
2022-12-31 | 6000 | 26.7 million | 6.9 million | - |
VERA Cost of Revenue
No data available :(
VERA
Price: $43.44
52 week price:
Earnings Per Share: -2.25 USD
P/E Ratio: -15.11
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 367897
Market Capitalization: 2.6 billion